Atwood Brian G
SEC-identified person · CIK 1266567 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Phoenix Biotech Acquisition Corp. PBAX | Director · Chief Executive Officer | filed 2021–2026 |
| Launch One Acquisition Corp. LPAAU | Director | filed 2024–2024 |
| Atreca, Inc. BCEL | Director | filed 2019–2023 |
| Clovis Oncology, Inc. CLVS | Director | filed 2011–2021 |
| Effector Therapeutics, Inc. LWAC | Director | filed 2021–2021 |
| Phaserx, INC. PZRX | Director | filed 2016–2017 |
| Opgen INC OPGN,OPGNW | Director | filed 2015–2016 |
| Veracyte, INC. VCYT | Director | filed 2013–2016 |
| Flexion Therapeutics Inc FLXN | Director | filed 2014–2016 |
| Glaukos Corp GKOS | Officer | filed 2015–2016 |
| Immune Design Corp. IMDZ | Director | filed 2014–2016 |
| Five Prime Therapeutics, INC. FPRX | Director | filed 2013–2015 |
| Inogen Inc INGN | Officer | filed 2014–2015 |
| Vivani Medical, Inc. VANI | Officer | filed 2014–2014 |
| Cadence Pharmaceuticals INC CADX | Director | filed 2006–2014 |
| Trius Therapeutics Inc TSRX | Director | filed 2010–2013 |
| Helicos Biosciences Corp HLCS | Director | filed 2007–2009 |
| Pharmion Corp PHRM | Director | filed 2006–2008 |
| Insulet Corp PODD | Officer | filed 2007–2007 |
| Transcept Pharmaceuticals Inc TSPT | Officer | filed 2006–2006 |
| Alexza Pharmaceuticals Inc. ALXA | Officer | filed 2006–2006 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.